losartan has been researched along with cilazapril, anhydrous in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Clozel, JP; Fischli, W; Hess, P; Véniant, M | 1 |
| Baumgartner, HR; Clozel, JP; Hefti, F; Müller, RK; Osterrieder, W; Powell, JS | 1 |
| Bohlender, J; Dehmel, B; Ganten, D; Gross, V; Lippoldt, A; Luft, FC; Mervaala, E; Milia, AF | 1 |
| Agabiti-Rosei, E; Rizzoni, D | 1 |
| Schiffrin, EL | 1 |
| Chung, HS; Han, SW; Kim, HJ; Kim, SW; Lee, JU; Paik, DJ; Paik, SS; Park, IK; Park, MH; Ryu, JH | 1 |
| Cuzić, S; Knotek, M; Radović, N | 1 |
1 review(s) available for losartan and cilazapril, anhydrous
| Article | Year |
|---|---|
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Cilazapril; Humans; Hypertension; Irbesartan; Losartan; Perindopril; Tetrazoles | 2002 |
7 other study(ies) available for losartan and cilazapril, anhydrous
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Effects of renin-angiotensin system blockade in guinea pigs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Cilazapril; Cyclooxygenase Inhibitors; Disease Models, Animal; Furosemide; Guinea Pigs; Hypertension; Imidazoles; Indomethacin; Losartan; Nephrectomy; Oligopeptides; Pyridazines; Renin; Renin-Angiotensin System; Tetrazoles | 1992 |
Role of angiotensin II in injury-induced neointima formation in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Cell Division; Cilazapril; Endothelium, Vascular; Imidazoles; Losartan; Male; Pyridazines; Rats; Regeneration; Tetrazoles | 1991 |
Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Cilazapril; Diuresis; Humans; Hypertrophy, Left Ventricular; In Situ Hybridization; Kidney; Losartan; Male; Natriuresis; Nucleic Acid Hybridization; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Ribonucleases | 1999 |
Endothelial factors and microvascular hypertensive disease.
Topics: Acetylcholine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cilazapril; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2001 |
Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Doxorubicin; Drug Interactions; Drug Synergism; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Losartan; Male; Nephrosis, Lipoid; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule and interstitial cell apoptosis in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Caspase 3; Cell Proliferation; Cell Survival; Cell Transdifferentiation; Cilazapril; Disease Models, Animal; Epithelial Cells; Kidney Tubules; Losartan; Male; Rats; Rats, Wistar; Ureteral Obstruction | 2008 |